KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novartis Ag (NVS) Total Non-Current Liabilities (2016 - 2026)

Novartis Ag's Total Non-Current Liabilities history spans 15 years, with the latest figure at $100.0 million for Q1 2026.

  • On a quarterly basis, Total Non-Current Liabilities changed N/A to $100.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $100.0 million, a N/A change, with the full-year FY2025 number at $37.1 billion, up 26.15% from a year prior.
  • Total Non-Current Liabilities hit $100.0 million in Q1 2026 for Novartis Ag, down from $37.1 billion in the prior quarter.
  • Over the last five years, Total Non-Current Liabilities for NVS hit a ceiling of $37.1 billion in Q4 2025 and a floor of $100.0 million in Q1 2026.
  • Historically, Total Non-Current Liabilities has averaged $26.8 billion across 5 years, with a median of $29.4 billion in 2022.
  • Biggest five-year swings in Total Non-Current Liabilities: skyrocketed 51.45% in 2022 and later dropped 15.87% in 2023.
  • Tracing NVS's Total Non-Current Liabilities over 5 years: stood at $29.4 billion in 2022, then fell by 8.75% to $26.8 billion in 2023, then rose by 9.79% to $29.4 billion in 2024, then grew by 26.15% to $37.1 billion in 2025, then crashed by 99.73% to $100.0 million in 2026.
  • Business Quant data shows Total Non-Current Liabilities for NVS at $100.0 million in Q1 2026, $37.1 billion in Q4 2025, and $30.6 billion in Q2 2025.